Journal profile · ALLERGY-DERMATOLOGY
Postepy Dermatologii i Alergologii
ISSN 1642-395X · eISSN 2299-0046 · Termedia Publishing House Ltd. · POLAND · Quarterly · Founded 2001
Postepy Dermatologii i Alergologii: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.77; fully open access; APC about USD 472; median 45 days to acceptance (96 articles, last 24 months); community-reported acceptance: easy; 79 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Postepy Dermatologii i Alergologii is published by Termedia Publishing House Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis and Allergic Rhinitis and Sensitization, together about 27.8% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii is a bimonthly aimed at allergologists and dermatologists. Journal published under the patronage of Polish Society of Allergology. The journal is funded by Termedia Publishing House
From the journal's Aims & Scope
Research area (LetPub): ALLERGY-DERMATOLOGY
Editorial board by country: none in mainland China; most named Poland 66, United States 2, Germany 2, Canada 1, Netherlands 1 (77 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dermatology and Skin DiseasesMedicine10.4%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology9.9%
- Allergic Rhinitis and SensitizationMedicine7.6%
- Asthma and respiratory diseasesMedicine7.1%
- Urticaria and Related ConditionsMedicine5.9%
- Autoimmune Bullous Skin DiseasesMedicine4.8%
- Food Allergy and Anaphylaxis ResearchMedicine4.4%
- Acne and Rosacea Treatments and EffectsMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedEmbasePublisher website
Other: MNiSW
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.77LetPub ·
- CiteScore 2026-06
- 3.4LetPub ·
- SJR 2026-06
- 0.52LetPub ·
- SNIP 2026-06
- 0.79LetPub ·
- h-index
- 19LetPub ·
- h-index
- 53OpenAlex ·
- i10-index
- 586OpenAlex ·
- 2-year mean citedness
- 1.42OpenAlex ·
- Self-citation rate
- 5.6%LetPub ·
- Share of gold OA articles
- 98.51%LetPub ·
Volume
- Articles per year
- 76LetPub ·
Articles by year OpenAlex count · 1,710 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 60 | 60 | 1 |
| 2025 | 79 | 79 | 90 |
| 2024 | 115 | 115 | 269 |
| 2023 | 119 | 119 | 569 |
| 2022 | 141 | 141 | 1,024 |
| 2021 | 201 | 201 | 1,534 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
45 daysMedian, submission to acceptance · P25–P75 28 days – 69 days
- Acceptance to online
- median 136 days (96 articles)
- Submission to online
- median 196 days
- Sample
- 96 articles with submission and acceptance dates (158 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Double anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | EUR 450 / PLN 2,050 | — | — | |
| LetPub | EUR 450 / PLN 2,050 | No | — | |
| Publisher website | EUR 450 | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- EUR 450
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- 200–250 words
- Keywords
- ≥ 3
- Manuscript length
- ≤ 3,500 words
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
Article types accepted9, with length limits
- book reviewsSpecial articles, Conference reports and Book reviews are invited by the Editorial Board.Length not stated
- conference reportsSpecial articles, Conference reports and Book reviews are invited by the Editorial Board.Length not stated
- letternal data or discuss published articles. Letters are not to exceed 1,000 words and 2 figures or tables, and 15 references – not to exceedmain text ≤ 1,000 words
- letters to the editor3,500 words and 6 figures or tables. • Letters to the Editor should not exceed 1,000 words, 2 figures or tables, and 15 references. • Word counts inclmain text ≤ 1,000 words · figures and tables ≤ 2 · references ≤ 15
- original articlect with editorial office. Article types Original articles Original articles should not exceed 3,500 words and 6 figures or tables. Original articles should be o…main text ≤ 3,500 words · figures and tables ≤ 6
- original articlesOriginal Articles and Letters to the Editor are standard features.Length not stated
- review articleA review article is expected to be comprehensive, scholarly, and balanced, presenting an expert curation of the literature on the topic of interest. Reviews are…abstract ≤ 100 words · figures and tables ≤ 2
- review articlesReview articles should be submitted only after consultation with the Editor-in-Chief.Length not stated
- special articlesSpecial articles, Conference reports and Book reviews are invited by the Editorial Board.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, Open access, Peer review, Plagiarism
- Authorship AUTHORSHIP CRITERIA AND/OR WHO SHOULD BE LISTED AS A CONTRIBUTOR
Ghostwriting/guest authorship penalized. Model summary
Termedia Publishing House in the matter of authorship criteria and/or who should be listed as a contributor, respects standards recommended by COPE (Committee on Publication Ethics). Detailed information about those criteria you can find in COPE Report publicationethics.org/files/2003pdf12_0.pdf.
Source ↗Publisher website ·- Conflicts of interest G. Conflict of interest
Conflict of interest. Authors are expected to describe sources of the research funding, a role of the potential sponsor in planning, executing and analysis in the study, and the influence (bias) the funding organization had on the content of the article. Other relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) providing potential sources of conflic…
Source ↗Publisher website ·- Publication ethics ETHICAL STANDARDS AND PROCEDURES
Follows COPE, ICMJE, WAME standards. Model summary
Termedia Publishing House is committed to upholding standards of ethical behaviour at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICJME) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order …
Source ↗Publisher website ·- Open access
Open access under CC BY-NC-SA 4.0. Model summary
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License
Source ↗Publisher website ·- Peer review Review Process
Double blind peer review; open access. Model summary
Articles are selected for publication in double blind selection system and published in open access system. The Editor-in-Chief selects reviewers - usually two or more - based on the submission topic and experts’ academic credentials (based on their academic achievements and review experience). Reviewer shall review by the electronic system on the basis of questions prepared for a specific title. …
Source ↗Publisher website ·- Plagiarism
Originality/plagiarism screening per ICMJE and WAME. Model summary
The journal applies procedures ensuring the originality of manuscripts in accordance with the criteria of the ICMJE (International Committee of Medical Journal Editors) and WAME (World Association of Medical Editors).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Termedia Publishing House Ltd.
- Country or region
- POLAND
- Language
- Polish, English
- Frequency
- Quarterly
- Founded
- 2001
- ISSN
- 1642-395X
- Electronic ISSN
- 2299-0046
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Postepy Dermatologii i Alergologii
What CAS zone is Postepy Dermatologii i Alergologii in?
In the 2025 upgraded edition of the CAS Journal Ranking, Postepy Dermatologii i Alergologii is in Zone 4 of Medicine, and in Zone 4 of the minor category Allergy / Dermatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Postepy Dermatologii i Alergologii?
The latest impact factor listed by LetPub is 1.77; CiteScore 3.4, h-index 53.
How long does peer review take at Postepy Dermatologii i Alergologii?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 45 days (interquartile range 28–69 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Postepy Dermatologii i Alergologii?
According to the journal's author guidelines: Abstract: 200–250 words; Keywords: ≥ 3; Manuscript length: ≤ 3,500 words; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Postepy Dermatologii i Alergologii based?
Of the 77 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (66), United States (2) and Germany (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Postepy Dermatologii i Alergologii?
According to LetPub and DOAJ records, Postepy Dermatologii i Alergologii is indexed in SCIE and Scopus. The journal's website also lists PubMed and Embase; that list has not been checked against each database.
Is Postepy Dermatologii i Alergologii open access, and what is the APC?
Postepy Dermatologii i Alergologii is a fully open-access journal. APC about USD 472.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .